Catalyst Pharmaceuticals, Inc.
CPRX
Classificação em ações
#4169
Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables,... Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is Firdapse, an amifampridine phosphate tablet formulation approved for managing Lambert-Eaton Myasthenic Syndrome (LEMS). Catalyst also provides Ruzurgi, a specific treatment option for pediatric patients diagnosed with LEMS. Beyond its existing products, Catalyst is actively investigating additional applications for Firdapse, including its potential use in treating MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and hereditary neuropathy with liability to pressure palsies. The company engages in various strategic collaborations, such as licensing agreements with BioMarin Pharmaceutical Inc., and a joint development and commercialization agreement with Endo Ventures Limited concerning a generic version of Sabril tablets. Previously known as Catalyst Pharmaceutical Partners, Inc., the company adopted its current name in May 2015.
Preço da ação
$31.49
Última sincronização: 2026-07-21
Valor de mercado
$3.85B
Variação (1 dia)
0.00%
Variação (1 ano)
53.24%
País
US
Negociar Catalyst Pharmaceuticals, Inc. (CPRX)
Categoria
Healthcare
Margem Operacional de Catalyst Pharmaceuticals, Inc. (CPRX)
Margem Operacional em October 2026 TTM: 44.83%
De acordo com os relatórios financeiros mais recentes e o preço das ações da Catalyst Pharmaceuticals, Inc., a margem operacional atual (TTM) é 44.83%. No final de 2023, a margem operacional era 21.80%.
Histórico da Margem Operacional da Catalyst Pharmaceuticals, Inc. de 2002 a 2026
Margem Operacional no final de cada ano
| Ano | Margem Operacional | Alterar |
|---|---|---|
| 2026 (TTM) | 44.83% | 12.98% |
| 2024 | 39.68% | 82.02% |
| 2023 | 21.80% | -54.14% |
| 2022 | 47.54% | 27.80% |
| 2021 | 37.20% | 7.24% |
| 2020 | 34.69% | 11.51% |
| 2019 | 31.11% | -100.44% |
| 2018 | -7,059.03% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | -100.00% |
| 2010 | -823.01% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
Margem Operacional de empresas semelhantes ou concorrentes
| Empresa | Margem Operacional | Diferença na Margem Operacional | País |
|---|---|---|---|
| 38.59% | -99.14% |
US
|
|
| -149.01% | -103.32% |
US
|
|
| 25.57% | -99.43% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -99.36% |
NL
|
O que é a Margem Operacional de uma empresa?
A Margem Operacional é um indicador essencial para avaliar a rentabilidade de uma empresa. Margens operacionais mais altas geralmente são melhores, pois mostram que uma empresa consegue vender seus produtos ou serviços por muito mais do que o custo de produzi-los. É calculada dividindo os lucros da empresa pela sua receita.